The Claim
Glucose limitation increases glutamine uptake in MUC1-overexpressing pancreatic cancer cells compared to control pancreatic cancer cells, indicating that MUC1 expression alters metabolic adaptation to nutrient stress.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When glucose is limited, pancreatic cancer cells with high levels of MUC1 protein take up more glutamine than cancer cells without high MUC1 levels, showing that MUC1 changes how these cells respond to low glucose conditions.
See the scientific wording
Glucose limitation increases glutamine uptake specifically in MUC1-overexpressing pancreatic cancer cells, but not in control cells, suggesting MUC1 alters metabolic adaptation to nutrient stress.
When glucose is scarce, pancreatic cancer cells with high levels of MUC1 take up more glutamine and convert it into aspartate, but they cannot use that aspartate to build DNA building blocks. This causes aspartate to pile up while DNA synthesis stops, trapping the cells in a growth pause.
What the research says
1 studyStudy: Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
When sugar is low, cancer cells with lots of MUC1 don’t use glutamine better — they actually get stuck and can’t make the parts they need to grow, unlike other cells. So MUC1 doesn’t help them adapt; it makes things worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.